Cefiderocol for treating severe drug-resistant gram-negative bacterial infections

  • Health technology evaluation
  • HTE2
  • Published: 

We have moved HTE2 to become 'antimicrobial resistance guidance'. This is to better reflect what the purpose of this product is and to help you find relevant content more quickly. The guidance itself has not changed.

See antimicrobial resistance guidance 2 on cefiderocol for treating severe drug-resistant gram-negative bacterial infections.